1933 Inds Stock Price, News & Analysis

1933 Industries Inc. (TGIFF) is a Nevada-based licensed wholesale producer in the cannabis sector. The company focuses on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its offerings are produced in a 68,000 sq. ft. indoor facility and are marketed directly to retail dispensaries, with AMA-branded flower, infused pre-rolls, and in-house boutique concentrates described as consistently ranking among the top products sold in Nevada.

1933 Industries is characterized in its disclosures as a Nevada-focused cannabis cultivator and producer. The company operates through its cultivation and production subsidiary, Alternative Medicine Association LC (AMA), which is centred on the medical and adult-use cannabis market in the state of Nevada. According to company statements, AMA-branded products are wholesaled to retail accounts across Nevada and the company is a key supplier in the Las Vegas market.

Business focus and operations

The company describes its core business as the wholesale production of cannabis flower, pre-rolls and boutique concentrate products under the AMA brand, with products sold to retail dispensaries rather than directly to consumers. Its operations emphasize quality and value offerings, and its communications highlight AMA’s rankings as a top seller by volume in Nevada, including strong positions in both the concentrates and flower categories.

1933 Industries reports that its product portfolio is cultivated at its 68,000 sq. ft. indoor facility in Nevada. The company emphasizes cultivation and extraction capabilities, with a focus on cannabis consumer products in multiple formats. Under the AMA brand, the company notes that its flower, infused pre-rolls and in-house boutique concentrates have achieved high sales rankings in the Nevada market.

Corporate structure and brands

1933 Industries owns 100% of Alternative Medicine Association (AMA), its cultivation and production subsidiary. The company has disclosed that FN Pharmaceuticals, a wholly owned subsidiary of 1933 Industries, completed the acquisition of the remaining membership interest in AMA, resulting in full ownership of this Nevada-based subsidiary. AMA is central to the company’s operations, providing cultivation and production for the medical and adult-use cannabis market in Nevada.

In addition to AMA, the company references Level X as another flagship brand under which it offers cannabis consumer products. The company has also referred to Canna Hemp assets in the context of reviewing those assets in light of regulatory developments in the hemp-derived CBD market, with a stated goal of potentially returning related products to the market, subject to alignment with new CBD regulations.

Market positioning and geographic focus

1933 Industries consistently describes itself as a Nevada-focused cannabis cultivator and producer. Its communications emphasize the company’s presence in the Nevada market, particularly in Las Vegas, where it identifies itself as a key supplier to retail accounts. The company highlights that AMA-branded products are top sellers by volume in Nevada, and that AMA has held high rankings in both the concentrates and flower categories during specific periods, reflecting its role in the state’s regulated cannabis market.

The company’s disclosures also reference broader U.S. cannabis and hemp regulatory developments, including changes under the U.S. Controlled Substances Act and amendments to the Farm Bill affecting hemp-derived products. 1933 Industries frames these developments as potentially affecting competition from hemp-derived THC businesses and creating opportunities for licensed operators in legal states such as Nevada.

Capital structure and debentures

1933 Industries has issued unsecured convertible debentures (referred to as the 2024 Debentures). The company has reported entering into and completing a Debenture Repurchase Agreement with arm's length parties for the repurchase and cancellation of a portion of its outstanding unsecured convertible debentures. These transactions reduced the principal value of debentures outstanding and removed repurchased amounts from the company’s liabilities.

The company has also communicated with debenture holders regarding the maturity of the 2024 Debentures and the associated conversion terms. According to these communications, the company does not have sufficient liquidity to repay the full principal amount of the 2024 Debentures in cash at maturity without materially impairing its ability to continue operating. As a result, the board of directors has encouraged holders to convert their debentures into equity, describing conversion as the most constructive and value-preserving outcome for stakeholders and as a means to strengthen the company’s balance sheet and preserve liquidity for ongoing operations.

Financial performance commentary

In its public disclosures, 1933 Industries has reported periods of positive net income and highlighted improvements in gross profit, margins and expenses. The company has noted consecutive profitable quarters and described its financial performance as reflecting cost-saving initiatives, operational efficiencies and a focus on disciplined financial controls. It has also stated that it continues to operate as a going concern and that management and the board believe the business has long-term value and a foundation for continued growth, while emphasizing the importance of maintaining adequate working capital to fund day-to-day operations.

These financial discussions are presented in the context of the Nevada cannabis market, where the company notes industry-wide pricing compression, increased competition and a slowdown in tourism. Despite these conditions, 1933 Industries reports that AMA’s brand position and rankings in Nevada remain resilient, supported by consistent product quality and value offerings.

Regulatory and industry context

The company’s news releases reference regulatory developments in the United States, including an executive order directing federal agencies to reclassify cannabis from a Schedule I to a Schedule III substance under the U.S. Controlled Substances Act, and amendments to the Farm Bill redefining hemp and THC standards. 1933 Industries characterizes these changes as potentially improving the operating environment for U.S. cannabis businesses by affecting tax treatment, banking access and competition from hemp-derived THC products.

In relation to the hemp-derived CBD market, the company has indicated that it is reviewing its Canna Hemp assets to ensure alignment with new CBD regulations and has expressed a goal of a potential future relaunch of related products. It also notes that restrictions on intoxicating hemp products may reduce competition from hemp-derived THC businesses and could increase demand for regulated cannabis products in legal states.

Stock listing and trading

1933 Industries Inc. is identified in its news releases as trading on the Canadian Securities Exchange (CSE) under the symbol TGIF and on the OTC market under the symbol TGIFF. These references indicate that the company’s shares are listed on the CSE and quoted on an OTC market in the United States.

Risk and liquidity considerations

The company’s communications to debenture holders emphasize liquidity constraints and the importance of preserving cash resources to support ongoing operations and business continuity. The board of directors has stated that the company is unable to satisfy repayment of the 2024 Debentures in cash at maturity without materially impairing its ability to continue operating, and has indicated that, absent sufficient conversions, the company may need to seek protection under applicable creditor protection legislation, with potential implications for unsecured creditors.

These disclosures underscore that 1933 Industries’ capital structure and liquidity management are important considerations for investors and debenture holders, alongside its operational performance in the Nevada cannabis market.